HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thompson, A J Articles by Stevenson, V L Search for Related Content PubMed PubMed Citation Articles by Thompson, A J Articles by Stevenson, V L

Clinical management of spasticity

¹ National Hospital for Neurology and Neurosurgery, Queen Square, London WC1, UK
² Institute of Neurology, Queen Square

Correspondence to:
Correspondence to:
Professor Alan J Thompson
Institute of Neurology, Queen Square, London WC1N 3BG, UK; a.thompson@ion.ucl.ac.uk

Received 1 July 2004
In final revised form 27 October 2004

Accepted for publication 28 October 2004

Abbreviations: FES, functional electrical stimulation; UMN, upper motor neurone

Keywords: spasticity; treatment; management

The first 150 words of the full text of this article appear below.

Spasticity is a common symptom seen in many neurological conditions, notably head injury, spinal cord injury, stroke, cerebral palsy, and multiple sclerosis. It is also the dominant feature in several rarer conditions such as tropical and hereditary spastic paraparesis. The fact that it is relevant to many chronic neurological conditions and that the absence of multidisciplinary input can result in progressive disability makes it an ideal model to reflect service provision In the future more long term care for such patients will be done in primary care and the community. It is therefore essential that a multidisciplinary approach is used with successful liaison between secondary, primary, and social care.

Optimum management of spasticity is dependent on an understanding of its underlying physiology, an awareness of its natural history, an appreciation of the impact on the patient, and a comprehensive approach to minimising that impact which is both multidisciplinary and . . . [Full text of this article]

This article has been cited by other articles:

				M. Giovannelli, G. Borriello, P. Castri, L. Prosperini, and C. Pozzilli Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis Clinical Rehabilitation, April 1, 2007; 21(4): 331 - 337. [Abstract] [PDF]

				J. E Harris and J. J Eng Paretic Upper-Limb Strength Best Explains Arm Activity in People With Stroke Physical Therapy, January 1, 2007; 87(1): 88 - 97. [Abstract] [Full Text] [PDF]

				J. C. Hobart, A. Riazi, A. J. Thompson, I. M. Styles, W. Ingram, P. J. Vickery, M. Warner, P. J. Fox, and J. P. Zajicek Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88) Brain, January 1, 2006; 129(1): 224 - 234. [Abstract] [Full Text] [PDF]

eLetters: